Cargando…

A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7

BACKGROUND: The natural history of clinical symptoms in the spinocerebellar ataxias (SCA)s has been well characterised. However there is little longitudinal data comparing cognitive changes in the most common SCA subtypes over time. The present study provides a preliminary longitudinal characterisat...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriarty, Amy, Cook, Arron, Hunt, Helen, Adams, Matthew E., Cipolotti, Lisa, Giunti, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917932/
https://www.ncbi.nlm.nih.gov/pubmed/27333979
http://dx.doi.org/10.1186/s13023-016-0447-6
_version_ 1782439024790601728
author Moriarty, Amy
Cook, Arron
Hunt, Helen
Adams, Matthew E.
Cipolotti, Lisa
Giunti, Paola
author_facet Moriarty, Amy
Cook, Arron
Hunt, Helen
Adams, Matthew E.
Cipolotti, Lisa
Giunti, Paola
author_sort Moriarty, Amy
collection PubMed
description BACKGROUND: The natural history of clinical symptoms in the spinocerebellar ataxias (SCA)s has been well characterised. However there is little longitudinal data comparing cognitive changes in the most common SCA subtypes over time. The present study provides a preliminary longitudinal characterisation of the clinical and cognitive profiles in patients with SCA1, SCA2, SCA3, SCA6 and SCA7, with the aim of elucidating the role of the cerebellum in cognition. METHODS: 13 patients with different SCAs all caused by CAG repeat expansion (SCA1, n = 2; SCA2, n = 2; SCA3, n = 2; SCA6, n = 4; and SCA7, n = 3) completed a comprehensive battery of cognitive and mood assessments at two time points, a mean of 7.35 years apart. All patients were evaluated clinically using the Scale for the Rating and Assessment of Ataxia (SARA) and the Inventory of Non-Ataxia Signs (INAS). Patients underwent structural MRI imaging at follow-up. RESULTS: Clinical scale scores increased in all patients over time, most prominently in the SCA1 (SARA) and SCA3 (INAS) groups. New impairments on neuropsychological tests were most commonly observed with executive functions, speed, attention, visual memory and Theory of Mind. Results suggest possible differences in cognitive decline in SCA subtypes, with the most rapid cognitive decline observed in the SCA1 patients, and the least in the SCA6 patients, congruent with observed patterns of motor deterioration. Minimal changes in mood were observed, and MRI measures of atrophy did not correlate with cognitive decline. CONCLUSION: As well as increasing physical impairment, cognitive decline over time appears to be a distinct aspect of the SCA phenotype, in keeping with the cerebellar cognitive-affective syndrome. Our data suggest a trend of cognitive decline that is different for each SCA subtype, and for the majority is related to the severity of cerebellar motor impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-016-0447-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4917932
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49179322016-06-24 A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7 Moriarty, Amy Cook, Arron Hunt, Helen Adams, Matthew E. Cipolotti, Lisa Giunti, Paola Orphanet J Rare Dis Research BACKGROUND: The natural history of clinical symptoms in the spinocerebellar ataxias (SCA)s has been well characterised. However there is little longitudinal data comparing cognitive changes in the most common SCA subtypes over time. The present study provides a preliminary longitudinal characterisation of the clinical and cognitive profiles in patients with SCA1, SCA2, SCA3, SCA6 and SCA7, with the aim of elucidating the role of the cerebellum in cognition. METHODS: 13 patients with different SCAs all caused by CAG repeat expansion (SCA1, n = 2; SCA2, n = 2; SCA3, n = 2; SCA6, n = 4; and SCA7, n = 3) completed a comprehensive battery of cognitive and mood assessments at two time points, a mean of 7.35 years apart. All patients were evaluated clinically using the Scale for the Rating and Assessment of Ataxia (SARA) and the Inventory of Non-Ataxia Signs (INAS). Patients underwent structural MRI imaging at follow-up. RESULTS: Clinical scale scores increased in all patients over time, most prominently in the SCA1 (SARA) and SCA3 (INAS) groups. New impairments on neuropsychological tests were most commonly observed with executive functions, speed, attention, visual memory and Theory of Mind. Results suggest possible differences in cognitive decline in SCA subtypes, with the most rapid cognitive decline observed in the SCA1 patients, and the least in the SCA6 patients, congruent with observed patterns of motor deterioration. Minimal changes in mood were observed, and MRI measures of atrophy did not correlate with cognitive decline. CONCLUSION: As well as increasing physical impairment, cognitive decline over time appears to be a distinct aspect of the SCA phenotype, in keeping with the cerebellar cognitive-affective syndrome. Our data suggest a trend of cognitive decline that is different for each SCA subtype, and for the majority is related to the severity of cerebellar motor impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-016-0447-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-22 /pmc/articles/PMC4917932/ /pubmed/27333979 http://dx.doi.org/10.1186/s13023-016-0447-6 Text en © Moriarty et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Moriarty, Amy
Cook, Arron
Hunt, Helen
Adams, Matthew E.
Cipolotti, Lisa
Giunti, Paola
A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
title A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
title_full A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
title_fullStr A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
title_full_unstemmed A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
title_short A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
title_sort longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917932/
https://www.ncbi.nlm.nih.gov/pubmed/27333979
http://dx.doi.org/10.1186/s13023-016-0447-6
work_keys_str_mv AT moriartyamy alongitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT cookarron alongitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT hunthelen alongitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT adamsmatthewe alongitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT cipolottilisa alongitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT giuntipaola alongitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT moriartyamy longitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT cookarron longitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT hunthelen longitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT adamsmatthewe longitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT cipolottilisa longitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7
AT giuntipaola longitudinalinvestigationintocognitionanddiseaseprogressioninspinocerebellarataxiatypes1236and7